OraSure (OSUR) Issues Update on Clinical Development Programs and OraQuick Manufacturing
Tweet Send to a Friend
OraSure Technologies, Inc. (NASDAQ: OSUR) today announced an update regarding the status of its application for U.S. FDA approval of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


